Recruiting
Phase 1
Phase 2

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

Sponsor:

Children's Oncology Group

Code:

NCT04870944

Conditions

Diffuse Midline Glioma, H3 K27M-Mutant

Metastatic Malignant Neoplasm in the Central Nervous System

Recurrent Diffuse Intrinsic Pontine Glioma

Recurrent Lymphoma

Recurrent Malignant Solid Neoplasm

Eligibility Criteria

Sex: All

Age: 12 - 30

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Bone Marrow Aspirate

Bone Marrow Biopsy

Echocardiography

FACT Complex-targeting Curaxin CBL0137

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information